Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]
Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]. // Clinical Immunology. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626001166?dgcid=rss_sd_all
Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]. Clinical Immunology. https://www.sciencedirect.com/science/article/pii/S1521661626001166?dgcid=rss_sd_all
“Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766].” Clinical Immunology.
@article{article491,
title = {Corrigendum to “Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis” [Clin. Immunol. 288 (2026) 110766]},
journal = {Clinical Immunology},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626001166?dgcid=rss_sd_all}
}